QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Studies-Reference-Cited by-同舟云学术

QVA149 Improves Lung Function, Dyspnea, and Health Status Independent of Previously Prescribed Medications and COPD Severity: A Subgroup Analysis from the SHINE and ILLUMINATE Studies

Published:2014 Issue:1 Volume:2 Page:48-60
ISSN:2372-952X
Container-title:Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation
language:
Short-container-title:J COPD F

Author:

Chapman Kenneth,Bateman Eric,Chen Hungta,Hu Hulin,Fogel Robert,Banerji Donald

Publisher

COPD Foundation

Subject

Pulmonary and Respiratory Medicine

Link

https://journal.copdfoundation.org/Portals/0/JCOPDF/Files/Volume2-Issue1/JCOPDF-2014-0140-Chapman.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies

;International Journal of Chronic Obstructive Pulmonary Disease;2020-04

2. The Effect of Curcumin in Patients with Chronic Fatigue Syndrome (or) Myalgic Encephalomyelitis Disparate Responses in Different Disease Severities;Pharmacovigilance and Pharmacoepidemiology;2019-11-19

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD

;International Journal of Chronic Obstructive Pulmonary Disease;2019-06

4. Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4;International Journal of Chronic Obstructive Pulmonary Disease;2018-12

5. When is dual bronchodilation indicated in COPD?;International Journal of Chronic Obstructive Pulmonary Disease;2017-08